Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
Active, not recruiting · NCT04115306 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-07-16 | NCT04115306 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Phoenix Molecular Designs | 2 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Banner Md Anderson Cancer Center | Gilbert | United States | 121 |
| City of Hope | Duarte | United States | 238 |
| City of Hope Chicago | Zion | United States | 6 |
| City of Hope Orange County, Lennar | Irvine | United States | 1 |
| Massachusetts General Hospital Cancer Center | Boston | United States | 178 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| Ohio State University | Columbus | United States | 169 |
| Profound Research | Farmington Hills | United States | 5 |
| South Texas Accelerated Research Therapeutics | San Antonio | United States | 7 |
| University of California, Los Angeles (UCLA) | Los Angeles | United States | 14 |